menu
    • menu

    Company profile for Icagen

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Icagen is an integrated early discovery partner, offering clients specialized technologies and deep scientific expertise to solve myriad challenges and optimize efficiency moving from target to lead. We work in multi-year, integrated programs, as well as individual projects to fill gaps in R&D efforts. The process begins with druggable targets, and our scientists bring exceptional experience in kinases, GPCR’s, ion channels...
    Icagen is an integrated early discovery partner, offering clients specialized technologies and deep scientific expertise to solve myriad challenges and optimize efficiency moving from target to lead. We work in multi-year, integrated programs, as well as individual projects to fill gaps in R&D efforts. The process begins with druggable targets, and our scientists bring exceptional experience in kinases, GPCR’s, ion channels and transporters. We work with clients to determine drug feasibility using state-of-the-art computational chemistry methods.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IcagenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Icagen Corp. (HQ) 4222 Emperor Blvd. Suite 350 Durham, NC 27703
    Telephone
    Telephone
    919.941.5206
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.icagen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/icagen/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/icagen_inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ligand and GSK Expand Global Collaboration and License Agreement
    Ligand and GSK Expand Global Collaboration and License Agreement

    21 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211221005684/en

    BUSINESSWIRE
    21 Dec 2021
    Share Share
    Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop
    Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop

    29 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200529005042/en

    BUSINESSWIRE
    29 May 2020
    Share Share
    Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
    Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs

    02 Apr 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/ligand-completes-acquisition-of-icagen-core-assets-partnered-programs-and-ion-channel-technologies/?s=79

    BIOSPACE
    02 Apr 2020
    Share Share
    Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
    Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs

    02 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200402005742/en

    BUSINESSWIRE
    02 Apr 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search